|drug1545||Hydroxychloroquine Sulfate 400 mg twice a day Wiki||1.00|
|drug1547||Hydroxychloroquine Sulfate 600 mg twice a day Wiki||1.00|
There is one clinical trial.
Recent data support the use of specific probiotic strains in a pediatric population. However, given the wide number of commercial products available, and contradictory data in the literature, healthcare providers and consumers are uncertain about whether or not to use probiotics in children and which one(s) to choose. While much progress has been made in understanding the gastrointestinal microbiota and its role in the balanced development of the infant immune system, the tolerability and efficacy of introducing beneficial microbes into the pediatric gastrointestinal tract remain underexplored. The purpose of this study is to investigate the effect of a 9 strain synbiotic consortium comprised of strains with previous pediatric clinical data for use in modulating airway sensitivity, gastrointestinal discomfort, dermatological inflammation, and reduction in the duration and severity of upper respiratory tract infections in a pediatric population.
Description: Assessed as the change from Baseline for the continuous variable estimated using a repeated measures analysis of covariance (ANCOVA) model.Measure: Change from baseline in weekly frequency of spontaneous bowel movements between groups. Time: Baseline-Day 84
Description: Assessed by daily stool characteristics reported using the seven-point ordinal BSFS score. The BSFS classifies human stool into seven types and scores them accordingly. Type 1: Separate hard lumps (hard to pass) Type 2: Sausage-shaped and lumpy Type 3: Like a sausage but with cracks on its surface Type 4: Like a sausage, smooth and soft Type 5: Soft blobs with clear cut edges (passed easily) Type 6: Fluffy pieces with ragged edges, a mushy stool Type 7: Watery, no solid pieces, entirely liquid. Types 1 and 2 indicate constipation, with 3 through 4 represent the ideal stool form, and 5, 6, and 7 tend towards diarrhea. For a given assessment week, the weekly stool consistency is defined as the sum of non-missing stool consistency score for spontaneous bowel movements during that week divided by the number of non-missing stool consistency scores for spontaneous bowel movements during that week. The parameter will be analyzed using repeated measures ANCOVA model.Measure: Change from baseline in Bristol Stool Form Scale (BSFS) score. Time: Baseline-Day 84
Description: Assessed as the percentage of participants who are spontaneous bowel movement responders and have ≥4 per week and an increase of ≥1 bowel movement per week from baseline, including at least 3 weeks during weeks 9-12.Measure: Overall spontaneous bowel movement response. Time: Baseline-Day 84
Description: Assessed by online daily symptom tracking of stool quality, regularity, ease of expulsion, bloating, flatulence, and intestinal transit time.Measure: Changes in subjective assessment of gut tolerability and efficacy as reported by parents or direct relative guardians. Time: Baseline-Day 84
Description: Microbiota composition will be identified through fecal samples for total genomic DNA extraction in participants supplemented with PDS-08 or placebo.Measure: Change in microbiota composition at 3 months as assessed by whole genome shotgun sequencing. Time: Baseline-Day 84
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports